Literature DB >> 2497817

Tetrahydroaminoacridine (THA) in Alzheimer's disease.

J Byrne1, T Arie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2497817      PMCID： PMC1836130          DOI： 10.1136/bmj.298.6677.845

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  23 in total

Review 1.  The aminopyridines.

Authors:  W E Glover
Journal:  Gen Pharmacol       Date:  1982

2.  Cholinergic side-effects of tetrahydroaminoacridine.

Authors:  G K Wilcock; D Surmon; D Forsyth; R Morgan
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

3.  Cholinergic side-effects of tetrahydroaminoacridine.

Authors:  R Levy
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

4.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

5.  Modest facilitation on memory in dementia with combined lecithin and anticholinerestase treatment.

Authors:  W H Kaye; N Sitaram; H Weingartner; M H Ebert; S Smallberg; J C Gillin
Journal:  Biol Psychiatry       Date:  1982-02       Impact factor: 13.382

6.  Cholinomimetic treatment fails to improve memory disorders.

Authors:  E D Caine
Journal:  N Engl J Med       Date:  1980-09-04       Impact factor: 91.245

7.  A post-mortem study of the cholinergic and GABA systems in senile dementia.

Authors:  M N Rossor; N J Garrett; A L Johnson; C Q Mountjoy; M Roth; L L Iversen
Journal:  Brain       Date:  1982-06       Impact factor: 13.501

8.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Authors:  E K Perry; B E Tomlinson; G Blessed; K Bergmann; P H Gibson; R H Perry
Journal:  Br Med J       Date:  1978-11-25

9.  Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.

Authors:  P Davies; R Katzman; R D Terry
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

10.  Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.

Authors:  W K Summers; J O Viesselman; G M Marsh; K Candelora
Journal:  Biol Psychiatry       Date:  1981-02       Impact factor: 13.382
View more
  7 in total

Review 1.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.

Authors:  E J Byrne; T Arie
Journal:  BMJ       Date:  1990-04-28

Review 3.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Tetrahydroaminoacridine in Alzheimer's disease.

Authors:  A C Walsh
Journal:  BMJ       Date:  1989-06-10

5.  Tetrahydroaminoacridine in Alzheimer's disease.

Authors:  P V Scott; M de Jong
Journal:  BMJ       Date:  1989-05-06

6.  Tetrahydroaminoacridine and Alzheimer's disease.

Authors:  E J Byrne; T Arie
Journal:  BMJ       Date:  1994-04-02

7.  Absorption, metabolism, and disposition of [14C]SDZ ENA 713, an acetylcholinesterase inhibitor, in minipigs following oral, intravenous, and dermal administration.

Authors:  F L Tse; R Laplanche
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.